 |
|
Excess pneumonia deaths linked to engine exhaust
April 15, 2008Atmospheric pollutants and mortalities in English local authority areas
Engine exhaust fumes are linked to excess deaths from pneumonia across England, suggests research published in the Journal of Epidemiology and Community Health.
The annual death toll is comparable to that caused by the London smog in 1952, suggests the author.
Data on atmospheric emissions, published causes of death, and expected causes of death for 352 local authority jurisdictions in England were combined to calculate the impact of pollution on death rates between 1996 and 2004.
Levels of air pollution varied substantially among the local authorities.
Calculations revealed that pneumonia, peptic ulcer, coronary and rheumatic heart diseases, lung and stomach cancers, and other diseases, were all associated with a range of emissions, as well as deprivation, smoking, binge drinking and a northern location.
Further analysis, allowing for the effects of the social factors, showed that pneumonia deaths were strongly and independently linked to emissions, with the exception of sulphur dioxide from coal burning.
The primary culprits were emissions associated with oil combustion, including vehicle exhaust fumes.
During the eight years of the study there were almost 390.000 deaths from pneumonia.
And 35 local authorities accounted for almost 54,000 of these deaths, or around15,,000 more than would be expected.
"Total annual losses as a result of air pollution probably approach those of the 1952 London smog," writes the author.
Because the links were so strong across all categories of exposure and deaths were so much higher than would be expected, this suggests that these pollutants directly damage lung tissue, he says.
Excess deaths from the progressive lung disease COPD (Chronic Obstructive Pulmonary Disease) and rheumatic heart disease, both of which are characterised by failing lung function, could also be precipitated by engine exhaust, he adds.
BMJ-British Medical Journal
Data on atmospheric emissions, published causes of death, and expected causes of death for 352 local authority jurisdictions in England were combined to calculate the impact of pollution on death rates between 1996 and 2004.
Levels of air pollution varied substantially among the local authorities.
Calculations revealed that pneumonia, peptic ulcer, coronary and rheumatic heart diseases, lung and stomach cancers, and other diseases, were all associated with a range of emissions, as well as deprivation, smoking, binge drinking and a northern location.
Further analysis, allowing for the effects of the social factors, showed that pneumonia deaths were strongly and independently linked to emissions, with the exception of sulphur dioxide from coal burning.
The primary culprits were emissions associated with oil combustion, including vehicle exhaust fumes.
During the eight years of the study there were almost 390.000 deaths from pneumonia.
And 35 local authorities accounted for almost 54,000 of these deaths, or around15,,000 more than would be expected.
"Total annual losses as a result of air pollution probably approach those of the 1952 London smog," writes the author.
Because the links were so strong across all categories of exposure and deaths were so much higher than would be expected, this suggests that these pollutants directly damage lung tissue, he says.
Excess deaths from the progressive lung disease COPD (Chronic Obstructive Pulmonary Disease) and rheumatic heart disease, both of which are characterised by failing lung function, could also be precipitated by engine exhaust, he adds.
BMJ-British Medical Journal
Pneumonia News and Current Pneumonia Events RSSFlu shot does not reduce risk of death
The widely-held perception that the influenza vaccination reduces overall mortality risk in the elderly does not withstand careful scrutiny, according to researchers in Alberta.
Stick with simple antibiotics for pneumonia to avoid super bugs, says researcher
Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study.
ETH Zurich study on salmonella self-destruction
ETH Zurich biologists, led by Professors Martin Ackermann and Wolf-Dietrich Hardt, in collaboration with Michael Doebeli of the University of British Colombia in Vancouver (CN), have been able to describe how random molecular processes during cell division allow some cells to engage in a self-destructive act to generate a greater common good, thereby improving the situation of the surviving siblings.
Silver is the key to reducing pneumonia associated with breathing tubes
People have long prized silver as a precious metal. Now, silver-coated endotracheal tubes are giving critically ill patients another reason to value the lustrous metal.
Bacterial pneumonia caused most deaths in 1918 influenza pandemic
The majority of deaths during the influenza pandemic of 1918-1919 were not caused by the influenza virus acting alone, report researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Infection Blocks Lung's Protective Response Against Tobacco Smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health.
Aspirin, acid blocker a-day keeps GI bleeding
For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding - an infrequent, but serious side-effect of regular aspirin use.
Vaccinated infants well protected against severe pneumococcal infection in Norway
Pneumococcus is a bacterium that can cause serious illnesses in some young children, e.g. meningitis, blood poisoning and pneumonia. Most of those who become ill are previously healthy without any known predisposing factors. The bacterium is present in the nose of up to 80 - 90% of healthy young children.
From foe to friend: Researchers use salmonella as a way to administer vaccines in the body
Researchers at the Biodesign Institute at Arizona State University have made a major step forward in their work to develop a biologically engineered organism that can effectively deliver an antigen in the body. The researchers report that they have been able to use live salmonella bacterium as the containment/delivery method for an antigen.
Yale researchers discover Legionnaire microbe's tricks
Yale University researchers have shed new light how bacteria like the ones that cause Legionnaires' disease and Q-fever raise such havoc in human patients.
More Pneumonia News Articles
 | Pneumonia Before Antibiotics: Therapeutic Evolution and Evaluation in Twentieth-Century America by Scott H. Podolsky Pneumonia -- Osler's "Captain of the Men of Death" and still the leading infectious cause of death in the United States -- has until now received scant attention from historians. In Pneumonia Before Antibiotics, clinician-historian Scott H. Podolsky uses pneumonia's enduring prevalence and its centrality to the medical profession's therapeutic self-identity to examine the evolution of... |
| Pulmonary Arterial Hypertension and Interstitial Lung Diseases: A Clinical Guide Interstitial lung disease (ILD) is a broad category of lung diseases that includes more than 150 disorders characterized by scarring or fibrosis of the lungs. In Pulmonary Arterial Hypertension and Interstitial Lung Disease: A Clinical Guide, renowned experts provide a state-of-the-art overview of the problems seen by physicians in the clinical management of ILDs. Divided into two sections, the... | |
 | Infectious Diseases in Critical Care Infections and their complications are a very important clinical area in the intensive care unit setting. Community-acquired infections and nosocomial infections both contribute to the high level of disease acquisition common among critically ill patients. The accurate diagnosis of nosocomial infections and the provision of appropriate therapies, including antimicrobial therapy effective against... |
| NIV Gift Bible GM by Zondervan An Italian Duo-Tone edition of the NIV Gift Bible for... | |
 | Chemokines in the Lung (Lung Biology in Health and Disease) Discusses the role of chemokines in mediating leukocyte trafficking, angiogenesis, tumor cell metastasis, host defense, trauma-induced lung injury, and the progression of AIDS in the lung. Studies cytokines as natural agents for modulating diseases that affect the... |
 | Nosocomial Pneumonia: Strategies for Management This multi-contributed text, co-ordinated by one of the leading authorities in the field, is a unique resource to cover in depth the management of the important issue of Nosocomial Pneumonia in respiratory medicine and critical care. This disease presents the clinician with a variety of challenges, in both diagnosis and management, all of which represent a significant concern for the welfare of... |
 | Sepsis: New Strategies for Management Sepsis is an important public health problem around the world. Severe sepsis carries significant morbidity, mortality and high costs. The incidence of sepsis is increasing because of the aging population, the growing number of immunocompromised hosts, the increasing use of invasive procedures, and, to a lesser extent, antibiotic resistance among pathogens. Despite recent advances in the... |
| Pneumonia Essentials 2008 by Burke A. Cunha Pneumonia Essentials is a concise, practical, and authoritative guide to the diagnosis, evaluation, treatment, and prevention of community-acquired pneumonia (CAP), nursing home-acquired pneumonia (NHAP), nosocomial (hospital-acquired) pneumonia (NP), tuberculosis (TB), chronic pneumonias, and pneumonias in the immunocompromised... | |
 | Community-Acquired Pneumonia Pneumonia (along with influenza) is the sixth leading cause of death in adults. About 4 million adults develop pneumonia each year in the US, resulting in 64 million days of restricted activity, 39 million days of bed confinement, and 10 million days of lost work. Yet the admission rates to hospital, length of stay, investigations, antimicrobial therapy and prevention strategies vary greatly... |
 | The Flu And Pneumonia Update (Disease Update) by Alvin Silverstein, Virginia B. Silverstein, Laura Silverstein Nunn |
| © 2008 BrightSurf.com |